Department of Woman, Child Health and Public Health, Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.
Department of Gynecologic Oncology, Gemelli Molise Spa, Università Cattolica del Sacro Cuore, Campobasso, Italy.
J Cancer Res Clin Oncol. 2021 Mar;147(3):845-852. doi: 10.1007/s00432-020-03372-x. Epub 2020 Sep 3.
The aim of this retrospective study was to compare surgical and survival outcome in only patients with early-stage UCSs managed by laparotomic surgery (LPT) versus minimally invasive surgery (MIS).
Data were retrospectively collected in four Italian different institutions. Inclusion criteria were UCS diagnosis confirmed by the definitive histological examination, and stage I or II according to the FIGO staging system.
Between August 2000 and March 2019, the data relative to 170 patients bearing UCSs were collected: of these, 95 were defined as early-stage disease (stage I-II) based on the histological report at the primary surgery, and thus were included in this study. Forty-four patients were managed by LPT, and 51 patients were managed by MIS. The operative time was lower in the MIS group versus the LPT group (p value 0.021); the median estimated blood loss was less in the MIS group compared to the median of LPT group (p value < 0.0001). The length of hospital stay days was shorter in the MIS patients (p value < 0.0001). Overall, there were eight (8.4%) post-operative complications; of these, seven were recorded in the LPT group versus one in the MIS group (p value 0.023). There was no difference in the disease-free survival (DFS) and overall survival (OS) between the two groups.
There was no difference of oncologic outcome between the two approaches, in face of a more favourable peri-operative and post-operative profile in the MIS group.
本回顾性研究旨在比较仅接受开腹手术(LPT)与微创手术(MIS)治疗的早期 UCS 患者的手术和生存结局。
数据从意大利四个不同机构进行回顾性收集。纳入标准为经最终组织学检查证实的 UCS 诊断,以及根据 FIGO 分期系统分期为 I 期或 II 期。
2000 年 8 月至 2019 年 3 月,共收集了 170 例 UCS 患者的数据:其中,95 例根据初次手术的组织学报告被定义为早期疾病(I 期-II 期),因此纳入本研究。44 例患者接受 LPT 治疗,51 例患者接受 MIS 治疗。MIS 组的手术时间低于 LPT 组(p 值 0.021);MIS 组的中位估计出血量低于 LPT 组(p 值<0.0001)。MIS 患者的住院时间更短(p 值<0.0001)。总体而言,术后有 8 例(8.4%)发生并发症;其中,7 例发生在 LPT 组,1 例发生在 MIS 组(p 值 0.023)。两组患者的无病生存率(DFS)和总生存率(OS)无差异。
在 MIS 组具有更有利的围手术期和术后情况的情况下,两种方法的肿瘤学结局没有差异。